Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC).
Lukas Rob
No relevant relationships to disclose
Jirina Bartunkova
Employment or Leadership Position - Sotio
Research Funding - Sotio
David Cibula
Research Funding - Sotio
Pawel Knapp
No relevant relationships to disclose
Zuzana Namestkova
Employment or Leadership Position - Sotio
Radek Spisek
Employment or Leadership Position - Sotio
Jan Waclav
Employment or Leadership Position - Sotio
Peter Mallmann
No relevant relationships to disclose